Clinical Trials Browser

Phase 1/2 × INDUSTRY × immunotoxin HA22 × Clear all

NCT01030536 2018-04-09

Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)

Phase 1/2 Completed

23 enrolled 26 charts

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell